Skip to Main Content

Paper Details

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.
Gut
18
2018
Author NameAffiliation
Maryou B LambrosThe CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research
Jorge S Reis-FilhoMemorial Sloan Kettering Cancer Center
Alan AshworthUCSF Helen Diller Family Comprehensive Cancer Center
  • 1 - 3

Datasets

Release 1.2